References:
1. Woo, P., Ng, B., Wong, J., Ng, O., Chan, T., Kwok, N. F., & Chan, K.
Y. (2021). The protean manifestations of central nervous system
IgG4-related hypertrophic pachymeningitis: a report of two
cases. Chinese neurosurgical journal, 7(1), 13.
https://doi.org/10.1186/s41016-021-00233-5
2. Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M,
Stone JH. Therapeutic approach to IgG4-related disease: A systematic
review. Medicine (Baltimore). 2016 Jun;95(26): e4002. doi:
10.1097/MD.0000000000004002. PMID: 27368010; PMCID: PMC4937924.
3. Baptista B, Casian A, Gunawardena H, D’Cruz D, Rice CM. Neurological
Manifestations of IgG4-Related Disease. Curr Treat Options Neurol. 2017
Apr;19(4):14. doi: 10.1007/s11940-017-0450-9. PMID: 28374231; PMCID:
PMC5378735.
4. Hegade VS, Sheridan MB, Huggett MT. Diagnosis and management of
IgG4-related disease. Frontline Gastroenterol. 2019 Jul;10(3):275-283.
doi: 10.1136/flgastro-2018-101001. Epub 2018 Oct 31. PMID: 31288262;
PMCID: PMC6583577.
5. Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic
pachymeningitis: clinical features, diagnostic criteria, and treatment.
JAMA Neurol. 2014 Jun;71(6):785-93. doi: 10.1001/jamaneurol.2014.243.
PMID: 24733677.
6. Lin CK, Lai DM. IgG4-related intracranial hypertrophic
pachymeningitis with skull hyperostosis: a case report. BMC Surg. 2013
Sep 21; 13:37. doi: 10.1186/1471-2482-13-37. PMID: 24053604; PMCID:
PMC3856477.
7. Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S,
Stemmer-Rachamimov A, Deshpande V, Stone JH. IgG4-related disease and
hypertrophic pachymeningitis. Medicine (Baltimore). 2013
Jul;92(4):206-216. doi: 10.1097/MD.0b013e31829cce35. PMID: 23793110;
PMCID: PMC4553969.
8. Chan SK, Cheuk W, Chan KT, Chan JK. IgG4-related sclerosing
pachymeningitis: a previously unrecognized form of central nervous
system involvement in IgG4-related sclerosing disease. Am J Surg Pathol.
2009 Aug;33(8):1249-52. doi: 10.1097/PAS.0b013e3181abdfc2. PMID:
19561447.
9. Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot
L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C.
Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented
review. Neurol Neuroimmunol Neuroinflamm. 2019 May 7;6(4): e568. doi:
10.1212/NXI.0000000000000568. PMID: 31355304; PMCID: PMC6624094.
10. Lindstrom KM, Cousar JB, Lopes MB. IgG4-related meningeal disease:
clinico-pathological features and proposal for diagnostic criteria. Acta
Neuropathol. 2010 Dec;120(6):765-76. doi: 10.1007/s00401-010-0746-2.
Epub 2010 Sep 16. PMID: 20844883
11. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic
criteria for IgG4- related disease (IgG4-RD), 2011. Mod Rheumatol 2012;
22:21–30
12. Wang L, Chu X, Ma Y, Zhang M, Wang X, Jin L, Tan Z, Li X, Li X. A
Comparative Analysis of Serum IgG4 Levels in Patients with IgG4-Related
Disease and Other Disorders. Am J Med Sci. 2017 Sep;354(3):252-256. doi:
10.1016/j.amjms.2017.05.009. Epub 2017 May 24. PMID: 28918831.
13. Della-Torre E, Galli L, Franciotta D, Bozzolo EP, Briani C, Furlan
R, Roveri L, Sessa M, Passerini G, Sabbadini MG. Diagnostic value of
IgG4 Indices in IgG4-related hypertrophic pachymeningitis. J
Neuroimmunol. 2014 Jan 15;266(1-2):82-6. doi:
10.1016/j.jneuroim.2013.10.008. Epub 2013 Oct 22. PMID: 24289956.
14. Miyazaki H, Tabuse M, Ishiyama N, Kikuchi R, Ogihara T, Nanki K. A
case of multifocal fibrosclerosis presenting with chronic subdural
hematoma. Brain and Nerve. 2011; 63:795 –9. 8. He Z, Ding F, Rong J,
Gan Y.
15. A case of idiopathic hypertrophic cranial pachymeningitis presenting
as chronic subdural hematoma. J Zhejiang Univ (Med Sci). 2016; 45:540
–3.
16. Polycystic subdural hygroma associated with immunoglobulin
G4-related intracranial hypertrophic pachymeningitis: a case report
Kazumichi Ota*, Yoshihiko Nakazato, Risa Okuda, Ryu Yokoyama, Hitoshi
Kawasaki, Naotoshi Tamura and Toshimasa Yamamoto
17.Park IS, Kim H, Chung EY, Cho KW. Idiopathic hypertrophic cranial
pachymeningitis misdiagnosed as acute subtentorial hematoma. Journal of
Korean Neurosurgical Society. 2010 Aug;48(2):181-184. DOI:
10.3340/jkns.2010.48.2.181.
18. Lee YS, Lee HW, Park KS, Park SH, Hwang JH (2014) Immunoglobulin
g4-related hypertrophic pachymeningitis with skull involvement. Brain
Tumor Res Treat 2(2):87–91.
19. Raj R. IgG4-related lung disease. Am J Respir Crit Care Med. 2013
Sep 1;188(5):527-9. doi: 10.1164/rccm.201306-1121ED. PMID: 23992587.
20.Wyrostek S, Chakrabarti S, Baldwin K, Avila JD. A Case of
Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and
c-ANCA. Case Rep Neurol. 2019 Oct 28;11(3):290-294. doi:
10.1159/000502569. PMID: 31762760; PMCID: PMC6872998.
21. Wallace ZS, Mattoo H, Mahajan VS, et al. Predictors of disease
relapse in IgG4-related disease following rituximab. Rheumatology
(Oxford) 2016; 55:1000–1008.
22. Ebbo M, Grados A, Samson M, et al. Long-term efficacy and safety of
rituximab in IgG4-related disease: data from a French nationwide study
of thirty-three patients. PLoS One 2017;12: e0183844. 29. Carruthers MN,
Topazian MD, Khosroshahi A, et al.
23.Rituximab for IgG4-related disease: a prospective, open-label trial.
Ann Rheum Dis 2015; 74:1171–1177.